Hims & Hers compounder received FDA warning letter| STAT
The Food and Drug Administration late last year issued a warning letter to MedisourceRx, a compounding pharmacy owned…
Hims & Hers won’t sell compounded version of Novo’s obesity pill
Hims & Hers said Saturday it will stop selling what it claims to be a cheaper, compounded version…
Do statins really cause those side effects? What the data shows
Far fewer people who could benefit from statins actually take the cholesterol-lowering drugs now. Many who start taking…
Hims & Hers announces Wegovy pill copy; Novo Nordisk vows legal action
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark,…
Novo Nordisk says Hims & Hers’ cheaper version of Wegovy pill is illegal
In an unexpected move, Hims & Hers is making available a cheaper, compounded version of the Wegovy weight…
Cigna settles FTC insulin case, commits to overhauling drug pricing
In this photo illustration, the Cigna Healthcare logo is displayed on a smartphone screen. Rafael Henrique | SOPA…
A restless leg syndrome drug led me to compulsive gambling
I was a tenured professor, a published novelist, and a married father of two sons when I lost…
Eli Lilly (LLY) earnings Q4 2025
Eli Lilly on Wednesday posted fourth-quarter earnings and revenue and 2026 guidance that blew past estimates, as demand…
Pfizer’s monthly obesity injection drove shows promise in trial
Smith Collection | Archive Photos | Getty Images Pfizer on Thursday said its experimental obesity drug, which it…
Pfizer (PFE) earnings Q4 2025
Albert Bourla, CEO of Pfizer, speaking on Squawk on the Street at the World Economic Forum in Davos,…
Eli Lilly CEO David Ricks talks Medicare coverage of obesity pills
Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major…
Eli Lilly plans $3.5 billion Pennsylvania plant for obesity drugs
Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Sept. 23, 2025. Antranik…